Clinical Trial Detail

NCT ID NCT03686683
Title Open- Label Trial of Sipuleucel-T Administered to Active Surveillance Patients for Newly Diagnosed Prostate Cancer (ProVent)
Recruitment Active, not recruiting
Gender male
Phase Phase III
Variant Requirements No
Sponsors Dendreon
Indications

prostate adenocarcinoma

Therapies

Sipuleucel-T

Age Groups: adult senior

No variant requirements are available.